secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-02-07T23:59:59+00:00
Accession:  0001731122-24-000207
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro increases authorized shares from 110M to 360M; common from 100M to 350M
--------------------------------------------------------------------------------

- Certificate of Amendment filed Feb 1, 2024, approved by stockholders on Jan 25, 2024.
- Total authorized capital stock raised from 110,000,000 to 360,000,000 shares.
- Authorized common stock increased from 100,000,000 to 350,000,000 shares.
- No change to preferred stock authorization or par value ($0.0001) stated.
- Purpose of increase not disclosed; may enable future financing or acquisitions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000207/0001731122-24-000207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000207/e5401_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-000207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer